Total Payments
$100,731
2024 Payments
$2,282
Companies
9
Transactions
47
Payment Breakdown by Category
Consulting$76,262 (75.7%)
Travel$9,941 (9.9%)
Research$7,282 (7.2%)
Other$6,300 (6.3%)
Food & Beverage$945.56 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $76,262 | 17 | 75.7% |
| Travel and Lodging | $9,941 | 20 | 9.9% |
| Unspecified | $7,282 | 2 | 7.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,300 | 2 | 6.3% |
| Food and Beverage | $945.56 | 6 | 0.9% |
Payments by Type
General
$93,449
45 transactions
Research
$7,282
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $69,168 | 27 | $0 (2023) |
| Takeda Development Center Americas, Inc. | $11,643 | 7 | $0 (2017) |
| SANOFI PASTEUR INC. | $5,852 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $5,385 | 2 | $0 (2018) |
| Emergent BioSolutions Inc. | $3,600 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $2,500 | 1 | $0 (2021) |
| Eli Lilly and Company | $2,282 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $264.68 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $35.25 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,282 | 1 | Eli Lilly and Company ($2,282) |
| 2023 | $5,865 | 6 | PFIZER INC. ($5,600) |
| 2022 | $15,721 | 7 | PFIZER INC. ($15,721) |
| 2021 | $11,600 | 5 | PFIZER INC. ($5,500) |
| 2020 | $12,780 | 5 | PFIZER INC. ($11,928) |
| 2019 | $7,004 | 2 | PFIZER INC. ($7,004) |
| 2018 | $16,593 | 5 | PFIZER INC. ($8,893) |
| 2017 | $28,887 | 16 | PFIZER INC. ($14,523) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Eli Lilly and Company | TALTZ (Drug) | — | In-kind items and services | $2,281.92 | Research |
| Study: EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) • Category: Immunology | ||||||
| 12/02/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $32.35 | General |
| 12/02/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $25.19 | General |
| 11/09/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $70.32 | General |
| 11/09/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $70.32 | General |
| 11/09/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $66.50 | General |
| 02/13/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $5,600.00 | General |
| 12/01/2022 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $3,373.84 | General |
| 12/01/2022 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $1,221.06 | General |
| 12/01/2022 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $484.07 | General |
| 12/01/2022 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $141.55 | General |
| 05/30/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 05/30/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 03/04/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| 11/05/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 08/02/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 07/19/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 02/16/2021 | Emergent BioSolutions Inc. | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 01/07/2021 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| 12/10/2020 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,050.00 | General |
| 05/26/2020 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $852.00 | General |
| 04/01/2020 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $7,600.00 | General |
| 02/10/2020 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $34.00 | General |
| 01/28/2020 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $243.82 | General |
| 02/18/2019 | PFIZER INC. | — | Travel and Lodging | Cash or cash equivalent | $204.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| None | SANOFI PASTEUR INC. | $5,000 | 1 |
| EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) | Eli Lilly and Company | $2,282 | 1 |
About Dr. Harry Greenberg, MD
Dr. Harry Greenberg, MD is a Gastroenterology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1689731200.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harry Greenberg, MD has received a total of $100,731 in payments from pharmaceutical and medical device companies, with $2,282 received in 2024. These payments were reported across 47 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($76,262).
Ad
Practice Information
- Specialty Gastroenterology
- Location Palo Alto, CA
- Active Since 01/02/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1689731200
Products in Payments
- FLUMIST (Drug) $5,385
- NO PRODUCT DISCUSSED (Drug) $5,000
- TALTZ (Drug) $2,282
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Palo Alto
Dr. Ryan Mcconnell, Md, MD
Gastroenterology — Payments: $133,556
Gastroenterology $133,556
Samer Eldika, M.d, M.D
Gastroenterology — Payments: $21,068
Gastroenterology $21,068
Ms. Joanne Imperial, Md, MD
Gastroenterology — Payments: $15,915
Gastroenterology $15,915
Erick Chan, Md, MD
Gastroenterology — Payments: $5,353
Gastroenterology $5,353
Andrew Roorda, M.d, M.D
Gastroenterology — Payments: $4,894
Gastroenterology $4,894
Dr. Yasser Bhat, M.d, M.D
Gastroenterology — Payments: $4,483
Gastroenterology $4,483